Brookfield Corp’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Brookfield Corp’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-52,823	Closed	-$2.49M	–	777
2022 Q3	$2.49M	Sell	52,823 -9,991	-16%	-$645K	0.01%	412
2022 Q2	$4.5M	Buy	62,814 +31,007	+97%	+$2.27M	0.02%	278
2022 Q1	$2.58M	Buy	31,807 +16,965	+114%	+$1.44M	0.01%	359
2021 Q4	$1.52M	Buy	+14,842	New	+$1.43M	0.01%	375
2021 Q2	–	Sell	-15,000	Closed	-$1.14M	–	668
2021 Q1	$1.14M	Buy	+15,000	New	+$1.13M	0.01%	351

Other funds holding SYNH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Brookfield Corp's SYNH Position: Q4 2022 in Review

Brookfield Corp sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 52,823 shares — an estimated $2.49M sold.

Brookfield Corp first reported a position in SYNH in Q1 2021 and held it in 5 quarters. The position peaked at $4.5M in Q2 2022. 305 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Brookfield Corp reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Brookfield Corp sold 52,823 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $2.49M.
Brookfield Corp first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2021 and held it in 5 quarters.
Brookfield Corp's Syneos Health, Inc. Class A Common Stock position peaked at $4.5M in Q2 2022.
305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Brookfield Corp's 13F filing for Q4 2022, filed 14 Feb 2023.